Jpmorgan Chase & CO Bioventus Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Bioventus Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 77,298 shares of BVS stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,298
Previous 106,506
27.42%
Holding current value
$1.06 Million
Previous $553,000
19.71%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BVS
# of Institutions
119Shares Held
40.1MCall Options Held
138KPut Options Held
137K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$179 Million24.48% of portfolio
-
Juniper Investment Company, LLC New York, NY6.83MShares$93.7 Million18.67% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.34MShares$73.2 Million2.05% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$32.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$22.8 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $845M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...